Dialysis Sups Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DIALYSIS SUPS, and what generic alternatives to DIALYSIS SUPS drugs are available?
DIALYSIS SUPS has one approved drug.
There is one US patent protecting DIALYSIS SUPS drugs.
There are four patent family members on DIALYSIS SUPS drugs in four countries and sixteen supplementary protection certificates in eight countries.
Summary for Dialysis Sups
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Dialysis Sups
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dialysis Sups | NORMOCARB HF 35 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-002 | Jul 26, 2006 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Dialysis Sups | NORMOCARB HF 25 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-001 | Jul 26, 2006 | RX | Yes | Yes | 7,300,674 | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dialysis Sups
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dialysis Sups | NORMOCARB HF 25 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-001 | Jul 26, 2006 | 5,945,449 | See Plans and Pricing |
| Dialysis Sups | NORMOCARB HF 35 | magnesium chloride; sodium bicarbonate; sodium chloride | SOLUTION;INJECTION | 021910-002 | Jul 26, 2006 | 5,945,449 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Dialysis Sups Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 0249693 | See Plans and Pricing |
| Canada | 2365787 | See Plans and Pricing |
| European Patent Office | 1347795 | See Plans and Pricing |
| Australia | 2620902 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Dialysis Sups Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1411900 | 2011C/016 | Belgium | See Plans and Pricing | PRODUCT NAME: NAPROXENE ET ESOMEPRAZOLE (SOUS LA FORME D'ESOMEPRAZOLE MAGNESIUM TRIHYDRATE); AUTHORISATION NUMBER AND DATE: BE382505 20101214 |
| 1499331 | C300615 | Netherlands | See Plans and Pricing | PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220 |
| 0984957 | C300483 | Netherlands | See Plans and Pricing | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYFRAAT; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17091/0263 - 0001 20110524 |
| 0124495 | SPC/GB01/006 | United Kingdom | See Plans and Pricing | PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
